Effects of filter pore size on efficacy of continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine

Critical Care Medicine

Volumn 26, Issue 4, 1998, Pages 730-737

  Lee, Patrice A ^a,b   Weger, Gayle W ^a   Pryor, Robert W ^a   Matson, James R ^a  

^a MEDICAL CITY DALLAS HOSPITAL   (United States)

^b AMGEN INC   (United States)

Author keywords

Extracorporeal; Gram positive infection; Mediators; Molecular weight exclusion; Multiple organ failure; Swine

Indexed keywords

ALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FILTER; CONTROLLED STUDY; FEMALE; HEMOFILTRATION; IMMATURITY; MALE; NONHUMAN; PRIORITY JOURNAL; SEPTICEMIA; STAPHYLOCOCCUS AUREUS; SURVIVAL TIME; SWINE;

ANIMALS; BACTEREMIA; DISEASE MODELS, ANIMAL; FEMALE; HEMOFILTRATION; MALE; MICROPORE FILTERS; STAPHYLOCOCCAL INFECTIONS; SWINE;

EID: 0031942790     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199804000-00024     Document Type: Article

References (22)

1. Lauer A, Saccaggi A, Ronco C, et al: Continuous arteriovenous hemofiltration in the critically ill patient: Clinical use and operational characteristics. Ann Intern Med 1983; 99: 455-160
2. Koller WF, Benzer HM, Pauser GF: CAVH in acute respiratory. In: Continuous Arteriovenous Hemofiltration (CAVH). Siebeith H-G, Mann H (Eds). Basel, Karger, 1985, pp 96-102
3. 2) in patients with adult respiratory distress syndrome during fluid removal by ultrafiltration. In: Continuous Arteriovenous Hemofiltration (CAVH). Siebeith H-G, Mann H (Eds). Basel, Karger, 1985, pp 111-115
4. Gotloib L, Barzilay E, Shustak A, et al: Sequential hemofiltration in nonoliguric high capillary permeability pulmonary edema of severe sepsis: Preliminary report. Crit Care Med 1984; 12: 997-1000
5. Coraim F, Wolner E: Management of cardiac surgery patients with continuous arteriovenous hemofiltration. In: Continuous Arteriovenous Hemofiltration (CAVH). Siebeith H-G, Mann H (Eds). Basel, Karger, 1985, pp 103-110
6. Coraim F, Fasol R, Stellwag F, et al: Continuous arteriovenous hemofiltration (CAVH) after cardiac surgery. In: Continuous Arteriovenous Hemofiltration (CAVH). Siebeith H-G, Mann H (Eds). Basel, Karger, 1985, pp 116-124
7. Ossenkoppele GJ, van der Meulen J, Bronsveld W, et al: Continuous arteriovenous hemofiltration as an adjunctive therapy for septic shock. Crit Care Med 1985; 13:102-104
8. Radzivil GG, Beloborodov VB, Broniakin IuV, et al: Hemosorption as a method of treating endotoxicosis in patients with septic shock of menigococcal etiology. Anestheziol Reanimatol 1987; 2:46-50
9. Gotloib L, Barzilay E, Shustak A, et al: Hemofiltration in septic ARDS. The artificial kidney as the artificial endocrine lung. Resuscitation 1986; 13: 123-132
10. Zobel G, Trop M, Ring E, et al: Arteriovenous hemofiltration in children with multiple organ system failure. Int J Artif Organs 1987; 10:233-238
11. Barzilay E, Kessler D, Berlot G, et al: Use of extracorporeal supportive techniques as additional treatment for septic-induced multiple organ failure patients. Crit Care Med 1989; 17:634-637
12. Lee PA, Matson JR, Pryor RW, et al: Continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine. Crit Care Med 1993; 21: 914-924
13. Hinshaw L, Taylor F, Chang A, et al: Staphylococcus aureus-induced septic shock: A pathophysiologic study. Circ Shock 1988; 26:257-265
14. Bradford MM: A refined and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-253
15. Barzilay E, Lev A, Lesmes C: Continuous hemofiltration as an adjunct therapy of acute organ system failure (AOSF). Rev Esp Anestesiol Reanim 1987; 34:459-461
16. Keh D, Gerlach M, Kuerer I, et al: Reduction in platelet trapping in membrane oxygenators by transmembrane application of gaseous nitric oxide. Int J Artif Organs 1996; 19:291-293
17. Mellgren K, Friberg LG, Mellgren G, et al: Nitric oxide in the sweep gas reduces platelet activation during experimental perfusion. Ann Thorac Surg 1996; 61:1194-1198
18. Millar AB, Armstrong L, van der Linden J, et al: Cytokine production and hemofiltration in children undergoing cardiopulmonary bypass. Ann Thorac Surg 1993; 56:1499-1502
19. Journois D, Pouard P, Greeley WJ, et al: Hemofiltration during cardiopulmonary bypass in pediatric cardiac surgery. Effects on hemostasis, cytokines and complement components. Anesthesiology 1994; 81:1181-1189
20. Tonnesen E, Hansen MB, Hohndorf K, et al: Cytokines in plasma and ultrafiltrate during continuous arteriovenous hemofiltration. Anaesth Intensive Care 1993; 21:752-758
21. Ronco C, Tetta C, Lupi A, et al: Removal of platelet activating factor in experimental continuous arteriovenous hemofiltration. Crit Care Med 1995; 23:99-107
22. Goldfarb S, Golper TA: Proinflammatory cytokines and hemofiltration membranes. J Am Soc Nephrol 1994; 5:228-232